CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Medical Officer bought 4,843 shares at $2.16 ($10,461)
- 4 Open-market buy Director bought 727 shares at $2.16 ($1,570)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $2.18 ($5,450)
- 4 Open-market buy President & CEO bought 15,210 shares at $2.08 ($31,637)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-1/A Offering Registration Statement
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 1 of 26 · 511 filings